Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Revised Cytogenetic Risk Stratification in Primary Myelofibrosis: A Mayo Clinic Study of 903 Patients

Ayalew Tefferi, MD, Emnet A Wassie, MD, Kebede Begna, MD, Christy Finke, BS, Alem A Belachew, Naseema Gangat, MD, Terra L Lasho, PhD, Animesh Pardanani, MBBS, PhD, Curtis A. Hanson, MD, Rhett Ketterling, MD

Blood (2014) 124 (21): 631.

https://doi.org/10.1182/blood.V124.21.631.631

Published: 2014

Journal Articles

Molecular and Prognostic Correlates of Cytogenetic Abnormalities in Chronic Myelomonocytic Leukemia: A Mayo Clinic-French Consortium Study

Emnet A Wassie, MD, Raphael Itzykson, Terra L Lasho, PhD, Olivier Kosmider, MD PhD, Christy Finke, BS, Curtis A. Hanson, MD, Rhett Ketterling, MD, Eric Solary, Ayalew Tefferi, MD, Mrinal M. Patnaik, MBBS

Blood (2014) 124 (21): 412.

https://doi.org/10.1182/blood.V124.21.412.412

Published: 2014

Journal Articles

Integration of Mutations and Karyotype Towards a Genetics-Based Prognostic Scoring System (GPSS) for Primary Myelofibrosis

Ayalew Tefferi, MD, Paola Guglielmelli, PhDMD, Christy Finke, BS, Terra L Lasho, PhD, Naseema Gangat, MD, Rhett Ketterling, MD, Curtis A. Hanson, MD, Animesh Pardanani, MBBS, PhD, Alessandro M. Vannucchi, MD

Blood (2014) 124 (21): 406.

https://doi.org/10.1182/blood.V124.21.406.406

Published: 2014

Journal Articles

Mutation-Enhanced International Prognostic Scoring System (MIPSS) for Primary Myelofibrosis: An AGIMM & IWG-MRT Project

Blood (2014) 124 (21): 405.

https://doi.org/10.1182/blood.V124.21.405.405

Published: 2014

Journal Articles

A Randomized Phase II Trial of Three Novel Regimens for Relapsed/ Refractory Acute Myeloid Leukemia (AML) Demonstrates Encouraging Results with a Flavopiridol-Based Regimen: Results of Eastern Cooperative Oncology Group (ECOG) Trial E1906

Mark R. Litzow, MD, Xin Victoria Wang, PhD, Martin P. Carroll, MD, Judith E. Karp, MD, Rhett Ketterling, MD, Scott H. Kaufmann, MD PhD, Hillard M. Lazarus, Selina M. Luger, MD, Elisabeth M. Paietta, PhD, Jacob M. Rowe, MD, Jessica K Altman, Keith W Pratz, MD, E. Randolph Broun, MD, Martin S. Tallman, MD

Blood (2014) 124 (21): 3742.

https://doi.org/10.1182/blood.V124.21.3742.3742

Published: 2014

Journal Articles

Blast Transformation in Chronic Myelomonocytic Leukemia: Risk Factors and Outcome

Mrinal M. Patnaik, MBBS, Emnet A Wassie, MD, Terra L Lasho, PhD, Curtis A. Hanson, MD, Rhett Ketterling, MD, Ayalew Tefferi, MD

Blood (2014) 124 (21): 1932.

https://doi.org/10.1182/blood.V124.21.1932.1932

Published: 2014

Journal Articles

Impact of Novel Agents on Young Patients with t(11;14) Multiple Myeloma

Jonas Paludo, MD, Nishanth Vallumsetla, MBBS, Shaji Kumar, MD, Rhett Ketterling, MD, Morie A Gertz, MD MACP, Angela Dispenzieri, MD, Martha Q Lacy, MD, Francis K Buadi, MD, David Dingli, MD, PhD, Utkarsh Painuly, MD, Nelson Leung, MD, Robert Kyle, MD MACP, S. Vincent Rajkumar, MD, Prashant Kapoor, MD

Blood (2014) 124 (21): 2059.

https://doi.org/10.1182/blood.V124.21.2059.2059

Published: 2014

Journal Articles

Chronic Myelomonocytic Leukemia in Young Patients: Molecular and Cytogenetic Predictors of Survival and Treatment Outcome

Mrinal M. Patnaik, MBBS, Emnet A Wassie, MD, Eric Padron, MD, Francesco Onida, MD, Raphael Itzykson, Terra L Lasho, PhD, Olivier Kosmider, MD PhD, Christy Finke, BS, Curtis A. Hanson, MD, Rhett Ketterling, MD, Rami S Komrokji, MD, Ayalew Tefferi, MD, Eric Solary

Blood (2014) 124 (21): 4633.

https://doi.org/10.1182/blood.V124.21.4633.4633

Published: 2014

Journal Articles

Genetic Determinants of Response and Survival in Momelotinib Treated Myelofibrosis Patients

Animesh Pardanani, MBBS, PhD, Ramy A. Abdelrahman, MBBCh, Christy Finke, BS, Terra L Lasho, PhD, Kebede Begna, MD, Aref Al-Kali, MD, William J. Hogan, MBChB, Mark R. Litzow, MD, Curtis A. Hanson, MD, Rhett Ketterling, MD, Ayalew Tefferi, MD

Blood (2014) 124 (21): 3162.

https://doi.org/10.1182/blood.V124.21.3162.3162

Published: 2014

Journal Articles

The Prognostic Advantage of Calreticulin Mutations in Myelofibrosis Might be Confined to Type 1 or “type 1-like” Calreticulin Variants

Ayalew Tefferi, MD, Terra L Lasho, PhD, Alexander Tischer, PhD, Emnet A Wassie, MD, Christy Finke, BS, Alem A Belachew, Rhett Ketterling, MD, Curtis A Hanson, MD, Animesh Pardanani, MBBS, PhD

Blood (2014) 124 (21): 3166.

https://doi.org/10.1182/blood.V124.21.3166.3166

Published: 2014

Journal Articles

Azacitidine With Or Without Entinostat For The Treatment Of Therapy-Related Myeloid Neoplasm: Further Results Of The E1905 North American Leukemia Intergroup Study

Thomas Prebet, MD, PhD, Zhuoxin Sun, PhD, Rhett Ketterling, MD, Peter L. Greenberg, MD, Amer M. Zeidan, MD, Mark R. Litzow, MD, Janice L. Gabrilove, MD, Harry Paul Erba, MD, PhD, Elisabeth Paietta, PhD, Magdalena Czader, MD, PhD, Steven D Gore, Martin S Tallman, MD

Blood (2013) 122 (21): 2777.

https://doi.org/10.1182/blood.V122.21.2777.2777

Published: 2013

Journal Articles

TP53 mutations and Polymorphisms in Primary Myelofibrosis,

Sania S Raza, MD, David Viswanatha, MD, Lori A Erickson, MD, Terra L Lasho, MT(ASCP), Christy Finke, BS, Ryan A Knudson, Rhett Ketterling, MD, Animesh D. Pardanani, MBBS, PhD, Ayalew Tefferi, MD

Blood (2011) 118 (21): 3840.

https://doi.org/10.1182/blood.V118.21.3840.3840

Published: 2011

Journal Articles

Integrative Genome-Wide DNA Methylation and Gene Expression Analysis Reveals Biological and Clinical Insights In Adult Acute Lymphoblastic Leukemia

Huimin Geng, PhD, Donna Neuberg, ScD, Elisabeth Paietta, PhD, Xutao Deng, PhD, Yushan Li, Yuan Xin, Janis Racevskis, PhD, Rhett Ketterling, MD, Susan M Richards, PhD, Martin S. Tallman, MD, Jacob M. Rowe, MD, Mark R. Litzow, MD, Olivier Elemento, PhD, Ari M. Melnick

Blood (2010) 116 (21): 852.

https://doi.org/10.1182/blood.V116.21.852.852

Published: 2010

Journal Articles

Deletion 5q in AML: A Clinicopathological Description of 79 Cases from a Single Institution

Rafael Santana-Davila, MD, Shernan G. Holtan, MD, Rhett Ketterling, MD, Ryan A Knudson, David P. Steensma, MD, FACP, Dong Chen, MD, PhD, James Hoyer, MD, Curtis A Hanson, MD, Ayalew Tefferi, MD

Blood (2008) 112 (11): 2523.

https://doi.org/10.1182/blood.V112.11.2523.2523

Published: 2008

Journal Articles

Rearrangements of IER3 Represent a Novel and Recurrent Molecular Abnormality in Myelodysplastic Syndromes (MDS)

David P. Steensma, MD, FACP, Jessemy D Neiger, MD, Julie C Porcher, MS, J. Jonathan Keats, PhD, Peter Leif Bergsagel, MD, Ryan A Knudson, Rafael Santana-Davila, MD, Rajiv Kumar, MD, Rhett Ketterling, MD

Blood (2008) 112 (11): 2679.

https://doi.org/10.1182/blood.V112.11.2679.2679

Published: 2008

Journal Articles

Two Distinct Subsets of dic(9;12)(p12;p11.2) among Children with B-Cell Precursor Acute Lymphoblastic Leukemia (ALL): PAX5-ETV6 and ETV6-RUNX1 Rearrangements: A Report from the Children’s Oncology Group.

Julie M. Gastier-Foster, PhD, Andrew J. Carroll, PhD, Denise Ell, BS, Richard Harvey, PhD, I-Ming Chen, PhD, Rhett Ketterling, MD, Aurelia Meloni-Ehrig, PhD, Kent E. Opheim, PhD, Shivanand Patil, PhD, Mark Pettenati, PhD, Kathleen Rao, PhD, ShiQi Wu, PhD, Nyla A. Heerema, PhD

Blood (2007) 110 (11): 1439.

https://doi.org/10.1182/blood.V110.11.1439.1439

Published: 2007

Journal Articles

14q32 Abnormalities and 13q Deletions Are Common in Primary Systemic Amyloidosis Using Cytoplasmic Immunoglobulin Fluorescence In Situ Hybridization (cIg-FISH).

Alan H. Bryce, MD, Rhett Ketterling, MD, Morie Gertz, MD, Steve Zeldenrust, MD, Martha Lacy, MD, Shaji Kumar, MD, Suzanne Hayman, MD, Francis Buadi, MD, Phillip Greipp, MD, John Lust, MD, Vincent Rajkumar, MD, Rafael Fonseca, MD, David Dingli, MD, Stephen Russell, MD, Robert Kyle, MD, Angela Dispenzieri, MD

Blood (2007) 110 (11): 2477.

https://doi.org/10.1182/blood.V110.11.2477.2477

Published: 2007

Journal Articles

Natural History, Genetic Aberrations and Survival Distinguish Primary Plasma Cell Leukemia from Multiple Myeloma with Leukemic Transformation.

Rodger E. Tiedemann, MD, PhD, Natalia Gonzalez-Paz, MD, Rafael Santana-Davila, MD, Wee Joo Chng, MD, Rhett Ketterling, MD, Morie A. Gertz, MD, Tammy Price-Troska, Kimberly Henderson, Philip R. Greipp, MD, S. Vincent Rajkumar, MD, Robert Kyle, MD, Angela Dispenzieri, MD, Martha Lacy, MD, Rafael Fonseca, MD

Blood (2006) 108 (11): 3587.

https://doi.org/10.1182/blood.V108.11.3587.3587

Published: 2006

Journal Articles

’Idiopathic’ Eosinophilia with an Occult T-Cell Clone: Prevalence, FIP1L1-PDGFRA Status, and Clinical Course.

Animesh Pardanani, MD, PhD, Christos Vaklavas, MD, Joseph Butterfield, MD, Rhett Ketterling, MD, Srdan Verstovsek, MD, PhD, Hagop Kantarjian, MD, Ayalew Tefferi, MD

Blood (2006) 108 (11): 2701.

https://doi.org/10.1182/blood.V108.11.2701.2701

Published: 2006

Journal Articles

Compendium of Karyotypic Abnormalities and Their Clinical Implications in Hyperdiploid Multiple Myeloma (H-MM).

Wee-Joo Chng, MD, Scott Van Wier, Gregory Ahmann, Rafael Santana-Davila, MD, Syed Jalal, PhD, Rhett Ketterling, MD, Peter Leif Bergsagel, MD, Marta Chesi, PhD, Mike Trendle, MD, Martin Oken, MD, Emily Blood, Kim Henderson, Robert Kyle, MD, Morie Gertz, MD, Martha Lacy, MD, Angela Dispenzieri, MD, Philip Greipp, MD, Rafael Fonseca, MD

Blood (2005) 106 (11): 1539.

https://doi.org/10.1182/blood.V106.11.1539.1539

Published: 2005

NARROW

Revised Cytogenetic Risk Stratification in Primary Myelofibrosis: A Mayo Clinic Study of 903 Patients

Molecular and Prognostic Correlates of Cytogenetic Abnormalities in Chronic Myelomonocytic Leukemia: A Mayo Clinic-French Consortium Study

Integration of Mutations and Karyotype Towards a Genetics-Based Prognostic Scoring System (GPSS) for Primary Myelofibrosis

Mutation-Enhanced International Prognostic Scoring System (MIPSS) for Primary Myelofibrosis: An AGIMM & IWG-MRT Project

A Randomized Phase II Trial of Three Novel Regimens for Relapsed/ Refractory Acute Myeloid Leukemia (AML) Demonstrates Encouraging Results with a Flavopiridol-Based Regimen: Results of Eastern Cooperative Oncology Group (ECOG) Trial E1906

Blast Transformation in Chronic Myelomonocytic Leukemia: Risk Factors and Outcome

Impact of Novel Agents on Young Patients with t(11;14) Multiple Myeloma

Chronic Myelomonocytic Leukemia in Young Patients: Molecular and Cytogenetic Predictors of Survival and Treatment Outcome

Genetic Determinants of Response and Survival in Momelotinib Treated Myelofibrosis Patients

The Prognostic Advantage of Calreticulin Mutations in Myelofibrosis Might be Confined to Type 1 or “type 1-like” Calreticulin Variants

Azacitidine With Or Without Entinostat For The Treatment Of Therapy-Related Myeloid Neoplasm: Further Results Of The E1905 North American Leukemia Intergroup Study

TP53 mutations and Polymorphisms in Primary Myelofibrosis,

Integrative Genome-Wide DNA Methylation and Gene Expression Analysis Reveals Biological and Clinical Insights In Adult Acute Lymphoblastic Leukemia

Deletion 5q in AML: A Clinicopathological Description of 79 Cases from a Single Institution

Rearrangements of IER3 Represent a Novel and Recurrent Molecular Abnormality in Myelodysplastic Syndromes (MDS)

Two Distinct Subsets of dic(9;12)(p12;p11.2) among Children with B-Cell Precursor Acute Lymphoblastic Leukemia (ALL): PAX5-ETV6 and ETV6-RUNX1 Rearrangements: A Report from the Children’s Oncology Group.

14q32 Abnormalities and 13q Deletions Are Common in Primary Systemic Amyloidosis Using Cytoplasmic Immunoglobulin Fluorescence In Situ Hybridization (cIg-FISH).

Natural History, Genetic Aberrations and Survival Distinguish Primary Plasma Cell Leukemia from Multiple Myeloma with Leukemic Transformation.

’Idiopathic’ Eosinophilia with an Occult T-Cell Clone: Prevalence, FIP1L1-PDGFRA Status, and Clinical Course.

Compendium of Karyotypic Abnormalities and Their Clinical Implications in Hyperdiploid Multiple Myeloma (H-MM).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only